Insider Shareholders with Direct Ownership of Tango Therapeutics, Inc. (TNGX)
This section provides a comprehensive overview of the insiders with direct ownership of Tango Therapeutics, Inc. (TNGX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Tango Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 0 | 2,504,900 | 16,859,075 $52.6 Million | 17 |
Sep 13, 2024
Reduced 0.4%
|
|
| 1,669,000 | 175,000 | 8,198,642 $25.6 Million | 9 |
Oct 16, 2023
Added 5.75%
|
|
| 0 | 1,508,000 | 6,690,642 $20.9 Million | 3 |
Oct 25, 2024
Reduced 8.64%
|
|
|
Bctg Holdings, Llc
> 10% Shareholder |
0 | 5,000 | 4,488,450 $14 Million | 1 |
Nov 20, 2020
Reduced 0.06%
|
|
Barbara Weber
Chief Executive Officer |
176,713 | 9,138 | 1,535,167 $4.79 Million | 4 |
Feb 07, 2024
Reduced 0.29%
|
|
Alan Huang
Chief Scientific Officer |
31,697 | 0 | 167,584 $522,862 | 1 |
Mar 01, 2023
Added 15.91%
|
|
Daniella Beckman
Chief Financial Officer |
72,255 | 3,725 | 132,397 $413,078 | 4 |
Feb 07, 2024
Reduced 1.35%
|
| 127,849 | 15,878 | 119,478 $372,771 | 5 |
Feb 07, 2024
Reduced 3.3%
|
|
| 0 | 374,731 | 108,793 $339,434 | 5 |
Jul 02, 2024
Reduced 46.62%
|
|
|
Douglas Barry
General Counsel |
46,757 | 2,776 | 43,981 $137,220 | 4 |
Feb 07, 2024
Reduced 2.99%
|
| 31,250 | 0 | 31,250 $97,500 | 4 |
Nov 18, 2024
Added 24.24%
|
|
| 14,687 | 0 | 14,687 $45,823 | 2 |
Jun 05, 2024
Added 24.19%
|
|
| 11,250 | 0 | 11,250 $35,100 | 2 |
Jun 05, 2024
Added 35.71%
|
|
| 11,250 | 0 | 11,250 $35,100 | 2 |
Jun 05, 2024
Added 35.71%
|
|
| 16,250 | 0 | 6,250 $19,500 | 2 |
Jun 05, 2024
Added 44.44%
|
|
| 5,000 | 0 | 5,000 $15,600 | 1 |
Jun 06, 2023
Added 50.0%
|
|
|
Reid M Huber
Director |
5,000 | 0 | 5,000 $15,600 | 1 |
Jun 06, 2023
Added 50.0%
|